+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lymphoma"

U.S. Hematology Diagnostics Market Size, Share & Trends Analysis Report by Product (Instrument, Consumable), Test Type, End-use (Hospital, Diagnostic Lab), Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

U.S. Hematology Diagnostics Market Size, Share & Trends Analysis Report by Product (Instrument, Consumable), Test Type, End-use (Hospital, Diagnostic Lab), Region, and Segment Forecasts, 2024-2030

  • Report
  • May 2024
  • 70 Pages
  • United States
From
BCL-2 (b-cell Lymphoma 2) Inhibitors Market 2024-2028 - Product Thumbnail Image

BCL-2 (b-cell Lymphoma 2) Inhibitors Market 2024-2028

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Von Willebrand Disease (VWD) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Thumbnail Image

Von Willebrand Disease (VWD) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • May 2023
  • 118 Pages
  • Global
From
Mantle Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Mantle Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 117 Pages
  • Global
From
Anaplastic Lymphoma Kinase Inhibitors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Anaplastic Lymphoma Kinase Inhibitors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 115 Pages
  • Global
From
AI In Oncology For Analytical Solutions Market Size, Share & Trends Analysis Report By Cancer Type, By Component, By Region, Analysis And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

AI In Oncology For Analytical Solutions Market Size, Share & Trends Analysis Report By Cancer Type, By Component, By Region, Analysis And Segment Forecasts, 2023 - 2030

  • Report
  • March 2023
  • 150 Pages
  • Global
From
Japan Cancer Supportive Care Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Cancer Supportive Care Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 82 Pages
  • Japan
From
Japan Haematology Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Thumbnail Image

Japan Haematology Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • August 2024
  • 80 Pages
  • Japan
From
Nasopharynx Cancer Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Nasopharynx Cancer Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • October 2023
  • 183 Pages
  • Global
From
Molecular Oncology Market - Global Forecast 2025-2030 - Product Thumbnail Image

Molecular Oncology Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
Leukapheresis Market by Product, by Application, by End-User, and By Region - Product Thumbnail Image

Leukapheresis Market by Product, by Application, by End-User, and By Region

  • Report
  • December 2024
  • 200 Pages
  • Global
From
Hemato Oncology Testing Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Hemato Oncology Testing Market Analysis & Forecast to 2024-2034

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Interventional Oncology Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Interventional Oncology Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
B-cell Lymphoma- Pipeline Insight, 2025 - Product Thumbnail Image

B-cell Lymphoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Natural Killer (NK)-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Natural Killer (NK)-Cell Lymphoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
Waldenstrom's Macroglobulinemia - Pipeline Insight, 2025 - Product Thumbnail Image

Waldenstrom's Macroglobulinemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
CNS Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

CNS Lymphoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Relapsed B-Cell Small Lymphocytic Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed B-Cell Small Lymphocytic Lymphoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

Lymphoma is a type of hematological malignancy that originates in the lymphatic system. It is characterized by the uncontrolled growth of lymphocytes, a type of white blood cell. Lymphomas can be either Hodgkin's or non-Hodgkin's, and can be either indolent or aggressive. Treatment options for lymphoma include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies. The lymphoma market is a subset of the larger hematology market, which includes treatments for a variety of blood-related diseases. The lymphoma market is driven by the increasing prevalence of the disease, as well as the development of new treatments. Companies in the lymphoma market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Gilead Sciences, Novartis, and Pfizer. Show Less Read more